Tag: BBRY

TTDZ, DEWM & Extended Watchlist

Triton Distribution Systems, Inc. TTDZ

Yesterday’s alert on TTDZ offered up opportunity for all, as the stock exploded out of the gate, trading from a low of .0052 all the way up to .009. That marked an intraday spike of 73% on nearly three times the 3-month average volume. Yesterday’s high represents a gain of 650% from our initial alert-low of .0012 on January 30th.

Perhaps most significantly is the fact that the stock finished out the session at .0088, very close to its high of day, and appears to want to gap up this morning.

As always, we need to watch carefully for the point where the stock runs out of steam, at which time we’ll be waiting for a pullback to lead to a future bounceplay opportunity. It’s all about being sharp-eyed and playing the current trend.

Dewmar International BMC, Inc. DEWM

DEWM, which has already afforded us gains in the 700%-range had some marijuana-related news out this morning that’ll lead us to watch this stock like a hawk today. The trading community has welcomed Dewmar’s intent to enter into the cannabis sector as evidenced by the hefty spikes on the chart we’ve witnessed. Today’s news furthers the company’s goals to that end, as they’ve announced the acquisition of a new subsidiary to house the company’s current and future cannabis holdings.

This is a story that we will definitely be paying attention to, as they attempt to become a player in the hemp industry, fueled by the Fed’s recently legalizing the cultivation of industrial hemp.

HOUSTON, TX–(Marketwired – Feb 20, 2014) – Dewmar International BMC, Inc. (OTCQB: DEWM) (OTCBB: DEWM) (“Dewmar” or “Company”), a leading provider of consumer brands to global markets announced that it has secured U.S. Hemp Corporation, Inc. d/b/a United States Hemp Corporation as a wholly-owned subsidiary for the purpose of holding and marketing the future hemp-related assets of Dewmar. >>> FULL PR

Extended Watchlist:
DIRV, MEET, ATRS, BCRX, BBRY (Options: Feb. 28th $10 Calls)

PROW, REVI & Extended Watchlist

Progress Watch Corp. PROW
–
We first introduced PROW to our reports on December 20th, when it was trading at a low of .0065. At that time, we pointed out the likelihood of a Golden Cross, and witnessed one just a couple weeks later. That signaled what would turn out to be an astonishingly impressive week-long breakout to a high of .0488, a rise of 650% from our initial alert price. Quite a move, considering it only took a little over three weeks to transpire.

PROW, is also extremely relevant to yesterday’s report on REVI, because it illustrates the potential power of the elusive Golden Cross chart formation.


Resource Ventures, Inc. REVI

We were pleased with the quick-strike opportunity our alert on REVI offered us yesterday. After opening at its low of day (.0074) the stock surged to a subsequent high of .0105, affording sharp traders the chance at gains of up to 42% After receding from that initial push, the stock found support at .008, bouncing back to .009 before closing at .0087, up 17.5% on the day and trading over 30% more volume than its 3mo. average.

We consider that an extremely solid performance from a stock being mentioned in our reports for the first time, and our call of the possible bounce from the .0074-level couldn’t have been timed any better.

We’re not done following this play, however, as it appears this company is doing everything in its power to improve its process and ensure its positioning for positive growth in the future. We’ll leave the recent press highlights we outlined in yesterday’s special report intact below for anyone who might have missed it; we’re looking forward to seeing how the company follows through with everything it currently has in the works. We also have the impending Golden Cross angle to follow, as we mentioned above; REVI is even closer to its potential Golden Cross than PROW was when we first mentioned it. So the potential for further gains in the days and weeks to come is certainly present. While past performances are no guarantee of future results, we’ve seen the Golden Cross scenario play out so many times to a positive effect, that we would be remiss not to point it out.

We’re also looking at a fresh news release the company put out this morning:

SILVERADO CA–(Marketwired – Jan 22, 2014) – Resource Ventures, Inc. (PINKSHEETS: REVI) President Bob Thompson announced today that the Company’s wholly owned subsidiary, Resources Printing and Graphics, Inc. (RP&G) has achieved a milestone in their Promotional Products, in that the division has grown to represent more than 25% of the company’s overall revenue.

“15 years ago RP&G started their Promotional Products division to satisfy the many customer requests received on a daily basis, RP&G’s printing customers kept pressing us to take on more of their other graphic needs; they like the 24/7 service we offer, and just wanted us to do more for them,” said Bob Thompson, President of Resource Ventures Inc. “Now over a half million products are offered from pens to cups to watches; anything you want to put logo or message on, we can likely do.”

RECENT PRESS HIGHLIGHTS:

– Company expects to report over $2M in revenue for year ending 12/31/13, a year-over-year rise in in excess of 40-50% (Report due no later than 04/01)

– Planned exchange uplisting, process for which could begin as early as Q2

– Company has committed to timely release of all pertinent data while it remains on OTC Pink

– New online store “WikiClickPrint.com” in “fast-track development” mode


www.resourcesprinting.com


Extended Watchlist:
BBRY, KOOL, EVOK, MSTX, DRWI, MELA, CVM

PROW, RNN & Extended Watchlist

Record-Setting ‘Green Rush’ Begins to Subside
–
Like all good things, the frenzied buying of countless pot stocks largely came to an end during yesterday’s session. It was a historic week; an overwhelming trend caused by sheer excitement over Colorado’s precedent-setting entry into the post-prohibition era, and we were happy to cover every step, taking profits along the way! Granted, the main wave of hysteria is now over, but our continued interest in the sector as a whole will not wane. As we stated previously, this story has only just begun to be written. Even as many of the huge runners we’ve tracked began to pull back, others maintained their trends, and still others came down to find support only to rebound and provide bounce opportunities. Rest assured, we will remain hot on the trail of any possible chance at added profits within this sector that has been so good to us for so long a time. For now, it’s time to shift gears and talk about some of our other interests that were forced to the back burner in all the excitement.

Progress Watch Corp. PROW

PROW has brought us some really impressive gains in the short time that we’ve been including it in our reports. When we first began talking about it (12/20/13, trading at .0065) we were especially interested in its tight share structure. That day, we said that the 50DMA rising sharply toward the 200DMA “should lead to a golden cross in the weeks and months ahead.”  That golden cross is now in progress as the stock ran into the close yesterday, attaining four cents, an increase of 515% off of the bottom we observed just twelve trading sessions ago.

As the value of the stock increases, we’re going to be looking for support levels to hold at areas of previous resistance. In the event of any pullbacks, we would like to see support hold at .025, and below that, .013, in order to remain bullish on PROW.

Rexhan Pharmaceuticals, Inc. RNN

Back on December 11th, we tagged RNN for the first time in our extended watchlist, and were rewarded with an intraday run of 26% from .4026 to  .5179. Even as marijuana stocks were breaking out over the past couple of days, we were still tracking this stock’s impressive run via our extended watchlists, and yesterday, saw a high of .765. That marks an increase of 90% from our observed low, a figure which is being pushed even higher this morning; pre-market trades have gone off as high as .929, so things could get very interesting from here. This spike seems to have been catalyzed by a recent press announcement from RNN.


The following PR was released under the headline: “RX-3117 has Shown Efficacy Against Gemcitabine-Resistant Human Cancer Cell Lines and a Broad-Spectrum of Anti-Cancer Activity “

ROCKVILLE, Md., Jan 08, 2014 (BUSINESS WIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors. RX-3117 is a next-generation cancer cell specific drug candidate that possesses a broad spectrum of anticancer activity with reduced side effects. In an exploratory Phase I clinical trial conducted in Europe, RX-3117 demonstrated oral bioavailability, and safety and tolerability in cancer patients with solid tumors. >> FULL PR

Extended Watchlist:
CNAT, BBRY, IMMU, BLDP, NSPH, RTRX